You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
OWC Pharmaceutical changes independent accounting firm
Street Talk Episode 51 - Goldman Talks Libor Transition, Recent SOFR Volatility
#ChangePays: Although Still Underrepresented, Women in the C-Suite are Driving Profitability
Cable Nets For Kids Enjoy Wide Carriage On Skinny Bundles
Power Forecast Briefing: Fleet Transformation, Under-Powered Markets, and Green Energy in 2018
OWC Pharmaceutical Research Corp. decided not to re-engage its independent auditor M&K CPAS PLLC for the year ending Dec. 31.
The company did not have any disagreements with the outgoing accounting firm.
OWC Pharmaceutical engaged Fahn Kanne & Co. Grant Thornton Israel as the independent registered public accounting firm for the fiscal year ending Dec. 31.
The changes were effective Dec. 23.